HSP90AB1 and cancer: More importantly, the highly variable levels of Hsp90, from as low as 1.7% to as high as 9% of the total cellular proteins in non-cancer cells, directly correlated with either extreme sensitivity or extreme resistance to a classical Hsp90 ATP-binding inhibitor [38].